p53 mutations and expression in breast carcinoma in situ.
about
Mammary epithelial cell transformation: insights from cell culture and mouse models.Mutations in p53, p53 protein overexpression and breast cancer survivalThe p53 tumor suppressor gene in ductal carcinoma in situ of the breast.Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 statusHigh-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.Serum organochlorines and breast cancer: a case-control study among African-American womenPathological characteristics of BRCA-associated breast cancers in Hispanics.The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review.Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer.New aspects of mitochondrial Uncoupling Proteins (UCPs) and their roles in tumorigenesis.Establishing a molecular continuum in breast cancer DNA microarrays and benign breast disease.Immunohistochemical characterization of canine neuroepithelial tumors.Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma.Genetic variation in TP53 and risk of breast cancer in a population-based case control study.Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations.p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast.
P2860
Q24810846-0A94AD5A-F3BC-4E27-93B1-324303C6E8E7Q33703486-6D4EFEA9-86CA-4A32-8EAB-B64C7A6F3823Q33810039-E78BAFEB-0AEB-44C6-9955-FE4A89394736Q33892868-D940D4D9-E5C6-4FB7-9976-36EA47CC5345Q34705321-5F90810B-2775-4C54-A95D-6A53F544BBC3Q35605800-8E913E4B-857C-487C-AC38-5D8BC32E6258Q35728963-56A5AA70-8703-4522-8FEC-8FAD5FC9CF12Q36478218-A3B60019-C49A-4087-AFC7-3FC539F30E05Q37251018-471C8AF8-1D62-423E-9019-BECA8F5E8CE5Q37277274-29662C68-DC86-401E-93D2-2214A68BE1FFQ37939833-3A0F2628-A911-4060-B5C6-5968D80BA952Q38458380-420368BA-2826-44B0-9B57-6D1CB59D6A4FQ43086056-7C81A05C-2B24-46B3-A03B-2E679CCD6CB4Q44107440-EB71501A-8A4B-41E5-B9DD-404EF72D3217Q53334287-D6C954F1-7181-4E9B-BEA4-BCBCF8BAD56FQ53348407-845BD56F-DE77-4B47-9642-94D9494CA3B7Q55335882-6AB9A205-D9FB-426F-809A-914603F02FF4
P2860
p53 mutations and expression in breast carcinoma in situ.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
p53 mutations and expression in breast carcinoma in situ.
@ast
p53 mutations and expression in breast carcinoma in situ.
@en
type
label
p53 mutations and expression in breast carcinoma in situ.
@ast
p53 mutations and expression in breast carcinoma in situ.
@en
prefLabel
p53 mutations and expression in breast carcinoma in situ.
@ast
p53 mutations and expression in breast carcinoma in situ.
@en
P2093
P2860
P1476
p53 mutations and expression in breast carcinoma in situ.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)64718-9
P407
P577
2000-01-01T00:00:00Z